Imanis Life Sciences Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Imanis Life Sciences's estimated annual revenue is currently $7.8M per year.(i)
  • Imanis Life Sciences's estimated revenue per employee is $155,000

Employee Data

  • Imanis Life Sciences has 50 Employees.(i)
  • Imanis Life Sciences grew their employee count by 9% last year.

Imanis Life Sciences's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M509%N/AN/A
#2
$7.4M48-35%N/AN/A
#3
$0.9M620%N/AN/A
#4
$0.3M2-91%N/AN/A
#5
$3.6M235%N/AN/A
#6
$0.9M6-33%N/AN/A
#7
$5M323%N/AN/A
#8
$14.7M959%N/AN/A
#9
$14.7M950%$20.5MN/A
#10
$27.9M14413%$39.1MN/A
Add Company

What Is Imanis Life Sciences?

Imanis is a biotechnology company specializing in oncolytic virotherapy and non-invasive reporter gene imaging for cell and virus tracking. As a leader in in vivo imaging, we are committed to advancing these technologies in pre-clinical and clinical studies. We offer reagents and well-characterized viruses to support research in regenerative medicine, gene therapy, oncolytic virotherapy and oncology drug discovery.

keywords:N/A

N/A

Total Funding

50

Number of Employees

$7.8M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Imanis Life Sciences News

2022-03-30 - Researchers in the Med City launch new test to track immunity ...

Imanis Life Sciences based in Rochester has created a new test to track immunity to the omicron variant - for at-risk patients.

2022-03-30 - Oral Vaccine Boosts COVID Immunity: study conducted on ...

The publication is a collaboration between researchers at Vyriad, Imanis Life Sciences, Regeneron Pharmaceuticals, and the University of...

2022-03-30 - Oral Vaccine Boosts COVID Immunity

The publication is a collaboration between researchers at Vyriad, Imanis Life Sciences, Regeneron Pharmaceuticals, and the University of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.8M504%N/A
#2
$8.2M509%N/A
#3
$6.5M500%N/A
#4
$6M5011%N/A
#5
$8.8M504%N/A